BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 108747
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.108747
Innovative insights into gut microbiota modulation in colorectal cancer: From microbial dysbiosis to therapeutic strategies
Semra Demirli Atici
Semra Demirli Atici, Department of General Surgery, Acibadem Kent Hospital, Izmir 35620, Türkiye
Author contributions: Demirli Atici S prepared, collected literature, performed analysis and wrote the manuscript, read and agreed to the published version of the manuscript.
Conflict-of-interest statement: The author declares no conflict of interest in publishing the manuscript.
Corresponding author: Semra Demirli Atici, MD, Department of General Surgery, Acibadem Kent Hospital, Ataşehir Mahallesi 8229/1, Sokak, Izmir 35620, Türkiye. smrdemirli@hotmail.com
Received: April 22, 2025
Revised: June 2, 2025
Accepted: June 27, 2025
Published online: November 15, 2025
Processing time: 206 Days and 6.3 Hours
Core Tip

Core Tip: This article clarifies the complex involvement of the gut microbiota in colorectal cancer (CRC), emphasizing the influence of microbial metabolites, immunological interactions, biofilm formation, and the therapeutic potential of fecal microbiota transplantation. It also presents innovative future directions, including engineered probiotics and microbiota-informed risk stratification models, which may advance precision oncology in CRC care.